Club Phase 1, the AHPPI’s French sister human pharmacology organisation, will be holding it’s next meeting in Paris on 22 March.
The draft outline of the programme is included below:
- Regulatory– Update on early phase clinical trial approval & on new EU regulation implementation – ANSM –Cecile Delval
- Immunogenicity … How to deal with it? Nathalie Mace –Sanofi
- Prediction of patient placebo response: from myth to reality. Impact on Proof of
- Concept clinical trials. Alvaro Pereira -Tools4Patients
- Use of modelling & simulation approaches in Clinical Development Speaker to be confirmed
- Definition of ”adversity” in toxicologic pathology – Results of the ESTP expert workshop – Practical considerations for NOAEL definition and first into human studies Xavier Palazzi- Sanofi
- Drug Drug Interactions & drug transporters: what’s new? Professor Jean Michel Scherrmann– Université Paris Descartes
- Translational medicine from animal to human : oncology models Patricia Vrignaud –Institut Gustave Roussy
- Translational medicine from animal to human : panic disorders Philippe Danjou – Biotrial Neurosciences
Use the following links to download the full draft Flyer and Registration Form.